Cell-penetrating peptides: design strategies beyond primary structure and amphipathicity

D Kalafatovic, E Giralt - molecules, 2017 - mdpi.com
Efficient intracellular drug delivery and target specificity are often hampered by the presence
of biological barriers. Thus, compounds that efficiently cross cell membranes are the key to …

Cell-surface interactions on arginine-rich cell-penetrating peptides allow for multiplex modes of internalization

S Futaki, I Nakase - Accounts of chemical research, 2017 - ACS Publications
Conspectus One of the recent hot topics in peptide-related chemical biology research is the
potential of cell-penetrating peptides (CPPs). Owing to their ability to deliver exogenous …

Enhancing endosomal escape for intracellular delivery of macromolecular biologic therapeutics

P Lönn, AD Kacsinta, XS Cui, AS Hamil, M Kaulich… - Scientific reports, 2016 - nature.com
Bioactive macromolecular peptides and oligonucleotides have significant therapeutic
potential. However, due to their size, they have no ability to enter the cytoplasm of cells …

Membrane internalization mechanisms and design strategies of arginine-rich cell-penetrating peptides

M Hao, L Zhang, P Chen - International Journal of Molecular Sciences, 2022 - mdpi.com
Cell-penetrating peptides (CPPs) have been discovered to deliver chemical drugs, nucleic
acids, and macromolecules to permeate cell membranes, creating a novel route for …

Cationic surfactants: Self-assembly, structure-activity correlation and their biological applications

LY Zakharova, TN Pashirova, S Doktorovova… - … Journal of Molecular …, 2019 - mdpi.com
The development of biotechnological protocols based on cationic surfactants is a modern
trend focusing on the fabrication of antimicrobial and bioimaging agents, supramolecular …

Cell-surface-retained peptide additives for the cytosolic delivery of functional proteins

JVV Arafiles, J Franke, L Franz… - Journal of the …, 2023 - ACS Publications
The delivery of functional proteins remains a major challenge in advancing biological and
pharmaceutical sciences. Herein, we describe a powerful, simple, and highly effective …

Peptides as pharmacological carriers to the brain: promises, shortcomings and challenges

S Parrasia, I Szabò, M Zoratti… - Molecular …, 2022 - ACS Publications
Central nervous system (CNS) diseases are among the most difficult to treat, mainly
because the vast majority of the drugs fail to cross the blood-brain barrier (BBB) or to reach …

Approaches and materials for endocytosis-independent intracellular delivery of proteins

N Chen, Y He, M Zang, Y Zhang, H Lu, Q Zhao… - Biomaterials, 2022 - Elsevier
The intracellular delivery of proteins is of great significance. For diseases such as cancer,
heart disease and neurodegenerative diseases, many important pharmacological targets …

Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell

P Lönn, SF Dowdy - Expert opinion on drug delivery, 2015 - Taylor & Francis
Introduction: Macromolecular therapeutics, including enzymes, transcription factors, siRNAs,
peptides and large synthetic molecules, can potentially be used to treat human diseases by …

Usefulness of cell-penetrating peptides and penetration accelerating sequence for nose-to-brain delivery of glucagon-like peptide-2

T Akita, R Kimura, S Akaguma, M Nagai… - Journal of Controlled …, 2021 - Elsevier
Neuropeptides are expected as therapeutic drug candidates for central nervous system
(CNS) disorders. Intracerebroventricular (icv) administration of glucagon-like peptide-2 (GLP …